6/14/2024  5:35:08 PM Chg. -0.150 Volume Bid5:40:00 PM Ask5:40:00 PM Market Capitalization Dividend Y. P/E Ratio
34.700EUR -0.43% 6,664
Turnover: 227,385.400
32.500Bid Size: 38 35.400Ask Size: 43 607.74 mill.EUR 2.74% 23.13

Business description

Boiron is a leading manufacturer of homeopathic products. BOIRON was founded in France almost a century ago, for the requirements of physicians and pharmacists wishing to obtain reliable and reproducible medicines.
 

Management board & Supervisory board

CEO
-
Management board
Christine Place, Jean-Christophe Bayssat, Valérie Lorentz-Poinsot
Supervisory board
Thierry Boiron, Anabelle Flory-Boiron, Anne Borfiga, Bruno Grange, Christine Boyer-Boiron, Grégory Walter, Jacky Abecassis, Jean-François Henaux, Jean-Pierre Boyer, Laurance Boiron, Michel Bouissou, Michèle Boiron, Philippe Brun, Stéphanie Chesnot, Sylvain Mossaz, Valérie Lorentz-Poinsot, Virginie Heurtaut
 

Company data

Name: BOIRON SA
Address: 2, avenue de l’Ouest Lyonnais,F-69510 Messimy
Phone: +33-4-72164000
Fax: +33-4-78596916
E-mail: internet@boiron.fr
Internet: www.boiron.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 24.11%
IPO date: 8/3/1998

Investor relations

Name: Fabrice Rey
IR phone: +33-4-78456100
IR Fax: -
IR e-mail: boironfinances@boiron.fr

Company calendar

CW 38 | 9/19/2024 Interim Report 2nd Quarter/6 Months
 

Main Shareholders

Familie Boiron
 
70.02%
Freefloat
 
24.11%
Mitarbeiter und Investment-Fond
 
5.67%
eigene Aktien
 
0.20%